SCHEMBL5555802

SCHEMBL5555802

CCCCNC(=O)OC1c2ccc(OC)cc2OC(C(C)C)C(=O)N1Cc1ccc(N(C)C)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 1/20 0.38
HCRTR2 O43614 1/20 0.38
MAPT P10636 4/20 0.36
SMN1; SMN2 Q16637 4/20 0.36
LMNA P02545 3/20 0.36
MAPK1 P28482 2/20 0.36
NFKB1 P19838 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
TP53 P04637 1/20 0.36
GAA P10253 1/20 0.35
KDM4E B2RXH2 2/20 0.35
POLB P06746 1/20 0.35
KMT2A Q03164 4/20 0.34
MEN1 O00255 3/20 0.34
NPC1 O15118 1/20 0.34
HPGD P15428 1/20 0.34
RAB9A P51151 1/20 0.34
ALDH1A1 P00352 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5556007 0.89 KMT2A (0.39) HCRTR1HCRTR2MAPTGAAKMT2A
SCHEMBL5555488 0.88 LMNA (0.40) HCRTR1HCRTR2MAPTSMN1; SMN2LMNA
SCHEMBL5556226 0.86 LMNA (0.41) HCRTR1HCRTR2MAPTLMNATP53
SCHEMBL5562156 0.80 ADRB2 (0.36) MAPTLMNAMAPK1TP53KMT2A
SCHEMBL5561753 0.79 ALDH1A1 (0.39) MAPTSMN1; SMN2LMNAMAPK1POLB
SCHEMBL5561387 0.78 GAA (0.40) MAPTSMN1; SMN2LMNAMAPK1NFKB1
SCHEMBL5561380 0.76 F2 (0.45) SMN1; SMN2LMNAMAPK1KDM4EKMT2A
SCHEMBL5556322 0.76 KMT2A (0.44) HCRTR1HCRTR2MAPTTP53GAA
SCHEMBL5556238 0.74 KCNA5 (0.43) HCRTR1HCRTR2MAPTLMNATP53
SCHEMBL5562398 0.73 MAPT (0.39) MAPTSMN1; SMN2LMNAKDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1631296-B1 2,3,4,5-TETRAHYDROBENZO¬F|¬1,4|OXAZEPINE-5-CARBOXYLIC ACID AMIDE DERIVATIVES AS GAMMA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE HOFFMANN LA ROCHE (CH) 2007-04-25 EP claimed